The Role of MIF in Type 1 and Type 2 Diabetes Mellitus

被引：47
作者：
Sanchez-Zamora, Yuriko I. [1 ]
Rodriguez-Sosa, Miriam [1 ]
机构：
[1] Univ Nacl Autonoma Mexico, Fac Estudios Super Iztacala, Unidad Biomed, Tlalnepantla 54090, Mex, Mexico
来源：
JOURNAL OF DIABETES RESEARCH | 2014年 / 2014卷
关键词：
MIGRATION-INHIBITORY FACTOR; RHEUMATOID-ARTHRITIS; THERAPEUTIC TARGET; ADIPOSE-TISSUE; POLYMORPHISMS; ASSOCIATION; SERUM; DYSFUNCTION; EXPRESSION; RESISTANCE;
D O I：
10.1155/2014/804519
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Autoimmunity and chronic low-grade inflammation are hallmarks of diabetes mellitus type one (T1DM) and type two (T2DM), respectively. Both processes are orchestrated by inflammatory cytokines, including the macrophage migration inhibitory factor (MIF). To date, MIF has been implicated in both types of diabetes; therefore, understanding the role of MIF could affect our understanding of the autoimmune or inflammatory responses that influence diabetic pathology. This review highlights our current knowledge about the involvement of MIF in both types of diabetes in the clinical environment and in experimental disease models.
引用
收藏
页数：6
相关论文
共 64 条
[1]   Enhancement of macrophage migration inhibitory factor (MIF) expression in injured epidermis and cultured fibroblasts [J].
Abe, R ;
Shimizu, T ;
Ohkawara, AA ;
Nishihira, J .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2000, 1500 (01) :1-9
[2]   MIF as a disease target: ISO-I as a proof-of-concept therapeutic [J].
Al-Abed, Yousef ;
VanPatten, Sonya .
FUTURE MEDICINAL CHEMISTRY, 2011, 3 (01) :45-63
[3]   Diagnosis and Classification of Diabetes Mellitus [J].
DIABETES CARE, 2010, 33 :S62-S69
[4]   Serum levels of macrophage migration inhibitory factor are associated with rheumatoid arthritis course [J].
Anais Llamas-Covarrubias, Mara ;
Valle, Yeminia ;
Elena Navarro-Hernandez, Rosa ;
Paola Guzman-Guzman, Iris ;
Guadalupe Ramirez-Duenas, Maria ;
Rangel-Villalobos, Hector ;
Estrada-Chavez, Ciro ;
Francisco Munoz-Valle, Jose .
RHEUMATOLOGY INTERNATIONAL, 2012, 32 (08) :2307-2311
[5]   Macrophage Migration Inhibitory Factor: a Potential Marker for Cancer Diagnosis and Therapy [J].
Babu, Spoorthy N. ;
Chetal, Gaurav ;
Kumar, Sudhir .
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (05) :1737-1744
[6]   INSULIN-DEPENDENT DIABETES-MELLITUS AS AN AUTOIMMUNE-DISEASE [J].
BACH, JF .
ENDOCRINE REVIEWS, 1994, 15 (04) :516-542
[7]   Anti-Inflammatory Therapy in Type 1 Diabetes [J].
Baumann, Bernd ;
Salem, Heba H. ;
Boehm, Bernhard O. .
CURRENT DIABETES REPORTS, 2012, 12 (05) :499-509
[8]   MECHANISM OF A REACTION IN VITRO ASSOCIATED WITH DELAYED-TYPE HYPERSENSITIVITY [J].
BLOOM, BR ;
BENNETT, B .
SCIENCE, 1966, 153 (3731) :80-&
[9]   Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis [J].
Bozza, M ;
Satoskar, AR ;
Lin, GS ;
Lu, B ;
Humbles, AA ;
Gerard, C ;
David, JR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (02) :341-346
[10]   Macrophage migration inhibitory factor: A regulator of innate immunity [J].
Calandra, T ;
Roger, T .
NATURE REVIEWS IMMUNOLOGY, 2003, 3 (10) :791-800
1234567